Diffusion Pharmaceuticals Inc

NASDAQ:DFFN   3:58:18 PM EDT
0.77
+0.07 (+10.50%)
Other Pre-Announcement

Diffusion Pharmaceuticals Reports Q3 2020 Results

Published: 11/12/2020 21:17 GMT
Diffusion Pharmaceuticals Inc (DFFN) - Diffusion Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Updates.
Diffusion - Expects 100-303 Covid Trial, Whether Or Not Co Decides to Implement Expansion,to Be Completed With Topline Data Available by Q1 2021 End.
Diffusion Pharmaceuticals - Believes Cash and Cash Equivalents Are Sufficient to Fund Operating Expenses & Capital Expenditures Into Q4 of 2022.
Diffusion Pharmaceuticals Inc Qtrly Net Loss per Share of Common Stock, Basic and Diluted $0.07.